DCP
CAH icon

Distillate Capital Partners’s Cardinal Health CAH Stock Holding History

Distillate Capital Partners’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4M Sell
77,646
-16,075
-17% -$3.34M 0.96% 43
2026
Q1 		$19.8M Buy
93,721
+708
+0.8% +$152K 1.04% 29
2025
Q4 		$19.1M Sell
93,013
-26,101
-22% -$4.91M 0.98% 32
2025
Q3 		$18.6M Buy
+119,114
New +$18.4M 0.97% 33
2023
Q1 		– Sell
-146
Closed -$11.2K – 39
2022
Q4 		$11.2K Buy
+146
New +$11.1K 1.04% 37

Other funds holding CAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Distillate Capital Partners's CAH Position: Q2 2026 in Review

Distillate Capital Partners reduced its Cardinal Health (CAH) stake by 17% in Q2 2026, selling an estimated $3.34M and leaving 77,646 shares worth $18.4M. The position accounts for 0.96% of the portfolio, ranked #43.

Distillate Capital Partners first reported a position in CAH in Q4 2022 and has held it in 5 quarters since. The position peaked at $19.8M in Q1 2026. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Distillate Capital Partners held 77,646 shares of Cardinal Health worth $18.4M as of Q2 2026.
  • Distillate Capital Partners sold 16,075 Cardinal Health shares in Q2 2026, an estimated $3.34M.
  • Cardinal Health made up 0.96% of Distillate Capital Partners's portfolio in Q2 2026, its #43 holding.
  • Distillate Capital Partners first reported a position in Cardinal Health in Q4 2022 and has held it in 5 quarters since.
  • Distillate Capital Partners's Cardinal Health position peaked at $19.8M in Q1 2026.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Distillate Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.